CORNOVUS PHARMACEUTICALS

cornovus-pharmaceuticals-logo

Cornovus Pharmaceuticals is a developer of a heart attack drug used to treat cardiac hypertrophy and heart failure. The technology increases myocardial cyclic guanosine-monophosphate which may play a role in cardia function and reperfusion enables heart attack victims to delay the onset of heart failure after a heart attack or injury. It was founded in 2011 and is headquartered in Farmington, Connecticut.

#People #Website #More

CORNOVUS PHARMACEUTICALS

Industry:
Health Care Health Diagnostics Medical Medical Device

Founded:
2011-01-01

Address:
Farmington, Connecticut, United States

Country:
United States

Website Url:
http://www.cornovus.com

Status:
Closed

Total Funding:
1.59 M USD


Current Employees Featured

not_available_image

Bruce Liang
Bruce Liang Founder @ Cornovus Pharmaceuticals
Founder

not_available_image

Robert Mark Van Allen
Robert Mark Van Allen CEO @ Cornovus Pharmaceuticals
CEO

Founder


not_available_image

Bruce Liang

Official Site Inspections

http://www.cornovus.com

  • Host name: a904c694c05102f30.awsglobalaccelerator.com
  • IP address: 76.223.54.146
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Cornovus Pharmaceuticals" on Search Engine